Going beyond boundaries in structural heart interventions?

Chairpersons: M.B. Leon, F. Maisano, A. Vahanian


To gain perspective from thought leaders on how the cathlab will evolve over the next 5-10 years
To participate to a unique discussion on the evolution of structural heart interventions
To learn the preferred strategy for combined cardiac diseases: while a staged approach may represent a preferable strategy in selected patients, concomitant treatment of combined cardiac diseases represents an appealing option in a majority of patients


Session objectives

A. Vahanian

What is structural heart intervention today?

M.B. Leon

How will TAVI technologies evolve over the next 5-10 years?

A. Linke

Transcatheter mitral valve replacement and repair: are new realities on the TMVR horizon?

R. S. Von Bardeleben

Transcatheter tricuspid valve interventions in 2017: unmet needs and future perspectives

J. Hausleiter

Case 1 - Mitral regurgitation and atrial fibrillation

F. Nietlispach

Case 2 - Bivalvular disesase: mitral and tricuspid regurgitation

J. Hausleiter

Case 3 - Bivalvular disesase: aortic stenosis and mitral regurgitation

C. Tamburino

Structural heart disease: glimpse into the future

F. Maisano

Session evaluation and key learnings

A. Vahanian


More from Abbott

Visit website